Racial/ethnic disparities in the use of medications for opioid use disorder (MOUD) and their effects on residential drug treatment outcomes in the US
Autor: | Gerald J. Stahler, Jeremy Mennis, David Baron |
---|---|
Rok vydání: | 2021 |
Předmět: |
Adult
Treatment completion Ethnic group 030508 substance abuse Treatment retention Toxicology Logistic regression 03 medical and health sciences Drug treatment 0302 clinical medicine medicine Ethnicity Humans Pharmacology (medical) 030212 general & internal medicine Residential Treatment Pharmacology business.industry Opioid use disorder Hispanic or Latino medicine.disease Moderation Opioid-Related Disorders Psychiatry and Mental health Treatment Outcome Opioid Pharmaceutical Preparations 0305 other medical science business Demography medicine.drug |
Zdroj: | Drug and alcohol dependence. 226 |
ISSN: | 1879-0046 |
Popis: | Background This study examines racial/ethnic disparities in the use of medications for opioid use disorder (MOUD) in residential treatment and the influence of race/ethnicity on the association between MOUD use and treatment retention and completion. Methods Data were extracted from SAMHSA’s 2015–2017 Treatment Episode Dataset-Discharge (TEDS-D) datasets for adult opioid admissions/discharges to short-term (ST) (30 days or less) (N = 83,032) or long-term (LT) (> 30 days) residential treatment settings (N=61,626). Logistic regression estimated the likelihood of MOUD use among racial/ethnic groups and the moderation of race/ethnicity on the probability of treatment completion and retention, controlling for background factors. Results After adjusting for covariates, compared to Whites, MOUD use was less likely for Blacks in ST (OR = 0.728) and LT settings (OR = 0.725) and slightly less likely for Hispanics in ST settings (OR = 0.859) but slightly more likely for Hispanics in LT settings (OR = 1.107). In ST settings, compared to Whites, the positive effect of MOUD on retention was enhanced for Blacks (OR = 1.191) and Hispanics (OR = 1.234), and the positive effect on treatment completion was enhanced for Hispanics (OR = 1.144). In LT settings, the negative association between MOUD and treatment completion was enhanced for Hispanics (OR = 0.776). Conclusions Access to medications for opioid use disorder in short term residential treatment is particularly beneficial for Blacks and Hispanics, though adjusted models indicate they are less likely to receive it compared to Whites. Results are mixed for long-term residential treatment. Residential addiction treatment may represent an important setting for mitigating low rates of medication initiation and early discontinuation for minority patients. |
Databáze: | OpenAIRE |
Externí odkaz: |